| Identification | Back Directory | [Name]
BP-1-102 | [CAS]
1334493-07-0 | [Synonyms]
BP-1-102
STAT3 Inhibitor XVIII
BP-1-102; BP1-102; BP 1-102.
STAT3 Inhibitor XVIII, BP-1-102
STAT3 INHIBITOR XVIII;BP1-102;BP 1-102
4-(N-(4-Cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-N-methylphenylsulfonamido)acetamido)-2-hydr
4-(N-(4-cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-N-methylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid
Benzoic acid, 4-[[(4-cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]-2-hydroxy- | [Molecular Formula]
C29H27F5N2O6S | [MDL Number]
MFCD29477477 | [MOL File]
1334493-07-0.mol | [Molecular Weight]
626.59 |
| Chemical Properties | Back Directory | [Boiling point ]
749.2±70.0 °C(Predicted) | [density ]
1.474±0.06 g/cm3(Predicted) | [storage temp. ]
Inert atmosphere,Store in freezer, under -20°C | [solubility ]
DMSO:15.0(Max Conc. mg/mL);23.9(Max Conc. mM) | [form ]
A crystalline solid | [pka]
3.15±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
BP-1-102 is a potent and selective STAT3 inhibitor. STAT3 is a cytoplasmic transcription factor that induces the expression of genes related to tumorigenesis. BP 1-102 exhibits antitumor activity against Waldenstrom macroglobulinemia, a rare form of B cell non-Hodgkin lymphoma. | [Biological Activity]
Primary Target
Stat3 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|